SCHEMBL3397377

SCHEMBL3397377

[CH2]c1ccc(F)cc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL103128 0.75
SCHEMBL29476041 0.75
SCHEMBL112382 0.72
Hydrochloric Acid SCHEMBL5794069 0.72 ALDH1A1 (0.62)
SCHEMBL29462674 0.72 ALDH1A1 (0.55)
SCHEMBL2562278 0.72
SCHEMBL129103 0.72
SCHEMBL27875052 0.70 ALDH1A1 (0.46)
Hydrochloric Acid SCHEMBL4372816 0.70 ALDH1A1 (0.59)
SCHEMBL31395718 0.69 ALDH1A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023169569-A1 TRICYCLIC HETEROCYCLE COMPOUNDS AS IAP ANTAGONISTS ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) 2023-09-14 WO disclosed
EP-2250157-A1 NOVEL HETEROCYCLIC COMPOUNDS Panacea Biotec Limited (IN) 2010-11-17 EP disclosed
WO-2009093269-A1 NOVEL HETEROCYCLIC COMPOUNDS PANACEA BIOTEC LIMITED (IN) 2009-07-30 WO disclosed